Integrated Annual Report

Overview

The report presents Hypera Pharma's 2023 performance across business, sustainability and governance. The company reported 10,301 employees, with women representing 51.50% of the workforce and 33% of the Board of Directors. It reported that 100% of energy consumed was of renewable origin, while total GHG emissions were 54,177.91 tCO2e. The report also describes its Climate Change Committee, TCFD disclosures, materiality process and externally reproduced limited assurance report.

Document

Report type: Integrated Report
Class: Embedded
Scope: Full report
Fiscal year: 2023
Period: 1 January 2023 – 31 December 2023
Language: English
Pages
File size
Restatement: Disclosed

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP

Commitments

UN Global Compact
UN Guiding Principles
Science Based Targets initiative

Ratings

GRI level
CDP score

Materiality

Assessment
Basis

Assurance

Provider
Level
Standard
Scope
Statement included
Metrics assured

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services

Overview